234 related articles for article (PubMed ID: 25166458)
1. Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes.
Ellis ML; Molinari V; Dobbs D; Smith K; Hyer K
Aging Ment Health; 2015; 19(6):507-16. PubMed ID: 25166458
[TBL] [Abstract][Full Text] [Related]
2. Variation in antipsychotic treatment choice across US nursing homes.
Huybrechts KF; Rothman KJ; Brookhart MA; Silliman RA; Crystal S; Gerhard T; Schneeweiss S
J Clin Psychopharmacol; 2012 Feb; 32(1):11-7. PubMed ID: 22198446
[TBL] [Abstract][Full Text] [Related]
3. An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses.
Phillips LJ; Birtley NM; Petroski GF; Siem C; Rantz M
J Psychiatr Ment Health Nurs; 2018 Oct; 25(8):463-474. PubMed ID: 29911331
[TBL] [Abstract][Full Text] [Related]
4. Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006.
Castle NG; Hanlon JT; Handler SM
Am J Geriatr Pharmacother; 2009 Jun; 7(3):143-50. PubMed ID: 19616182
[TBL] [Abstract][Full Text] [Related]
5. Reducing Antipsychotic Medication Use in Nursing Homes: A Qualitative Study of Nursing Staff Perceptions.
Simmons SF; Bonnett KR; Hollingsworth E; Kim J; Powers J; Habermann R; Newhouse P; Schlundt DG
Gerontologist; 2018 Jul; 58(4):e239-e250. PubMed ID: 28575301
[TBL] [Abstract][Full Text] [Related]
6. Educating Nursing Home Staff in Dementia Sensitive Communication: Impact on Antipsychotic Medication Use.
Shaw C; Williams KN; Perkhounkova Y
J Am Med Dir Assoc; 2018 Dec; 19(12):1129-1132. PubMed ID: 30471803
[TBL] [Abstract][Full Text] [Related]
7. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
Mamun K; Goh-Tan CY; Ng LL
Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
[TBL] [Abstract][Full Text] [Related]
8. Exploring Antipsychotic Prescribing Behaviors for Nursing Home Residents With Dementia: A Qualitative Study.
Walsh KA; Sinnott C; Fleming A; Mc Sharry J; Byrne S; Browne J; Timmons S
J Am Med Dir Assoc; 2018 Nov; 19(11):948-958.e12. PubMed ID: 30241987
[TBL] [Abstract][Full Text] [Related]
9. The quality of antipsychotic drug prescribing in nursing homes.
Briesacher BA; Limcangco MR; Simoni-Wastila L; Doshi JA; Levens SR; Shea DG; Stuart B
Arch Intern Med; 2005 Jun; 165(11):1280-5. PubMed ID: 15956008
[TBL] [Abstract][Full Text] [Related]
10. Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study.
Foebel AD; Liperoti R; Onder G; Finne-Soveri H; Henrard JC; Lukas A; Denkinger MD; Gambassi G; Bernabei R;
J Am Med Dir Assoc; 2014 Dec; 15(12):911-7. PubMed ID: 25262195
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment.
Briesacher B; Limcangco R; Simoni-Wastila L; Doshi J; Gurwitz J
J Am Geriatr Soc; 2005 Jun; 53(6):991-6. PubMed ID: 15935022
[TBL] [Abstract][Full Text] [Related]
12. Caregiver Perspectives About Using Antipsychotics and Other Medications for Symptoms of Dementia.
Kerns JW; Winter JD; Winter KM; Kerns CC; Etz RS
Gerontologist; 2018 Mar; 58(2):e35-e45. PubMed ID: 28402533
[TBL] [Abstract][Full Text] [Related]
13. Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial.
Richter C; Berg A; Fleischer S; Köpke S; Balzer K; Fick EM; Sönnichsen A; Löscher S; Vollmar HC; Haastert B; Icks A; Dintsios CM; Mann E; Wolf U; Meyer G
Implement Sci; 2015 Jun; 10():82. PubMed ID: 26037324
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drug use among elderly nursing home residents in the United States.
Kamble P; Chen H; Sherer J; Aparasu RR
Am J Geriatr Pharmacother; 2008 Oct; 6(4):187-97. PubMed ID: 19028374
[TBL] [Abstract][Full Text] [Related]
15. Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia.
Jessop T; Harrison F; Cations M; Draper B; Chenoweth L; Hilmer S; Westbury J; Low LF; Heffernan M; Sachdev P; Close J; Blennerhassett J; Marinkovich M; Shell A; Brodaty H
Int Psychogeriatr; 2017 Aug; 29(8):1391-1403. PubMed ID: 28266282
[TBL] [Abstract][Full Text] [Related]
16. Deficiency Citations on Inappropriate Psychotropics Use Related to Care for Behavioral Symptoms of Dementia.
Yoon JM; Trinkoff AM; Galik E; Storr CL; Lerner NB; Brandt N; Zhu S
J Am Med Dir Assoc; 2022 Nov; 23(11):1772-1779. PubMed ID: 35568094
[TBL] [Abstract][Full Text] [Related]
17. Involving the resident/decision maker in antipsychotic medication use.
Mort JR
S D Med; 2013 Apr; 66(4):148-9. PubMed ID: 23697039
[No Abstract] [Full Text] [Related]
18. CMS Strategies To Reduce Antipsychotic Drug Use In Nursing Home Patients With Dementia Show Some Progress.
Lucas JA; Bowblis JR
Health Aff (Millwood); 2017 Jul; 36(7):1299-1308. PubMed ID: 28679818
[TBL] [Abstract][Full Text] [Related]
19. Improving Nursing Home Compliance via Revised Antipsychotic Use Survey Tool.
Bach LL; Lazzaretto DL; Young CF; Lofholm PW
Consult Pharm; 2017 Apr; 32(4):228-238. PubMed ID: 28376988
[TBL] [Abstract][Full Text] [Related]
20. Improving the appropriateness of antipsychotic prescribing in nursing homes: a mixed-methods process evaluation of an academic detailing intervention.
Desveaux L; Saragosa M; Rogers J; Bevan L; Loshak H; Moser A; Feldman S; Regier L; Jeffs L; Ivers NM
Implement Sci; 2017 May; 12(1):71. PubMed ID: 28549480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
